Alternatives to Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Germany – Miscellaneous medical devices and products – Milchpumpen und Brustpumpensets

Germany – Imaging equipment for medical, dental and veterinary use – Radiologische Geräte

Germany – Counselling services – Betrieb eines Bewerbercenter mit Unterstützung bei der Antragstellung von SGB II-Grundsicherungsleistungen

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ruxolitinib, ATC D11AH09

Germany – Patient-monitoring system – Lieferung, Installation und Wartung eines Patientenüberwachungssystems

Germany – Operating techniques – Mietvertrag über Operationssystem da Vinci Xi-R Surgical System

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ixekizumab, ATC L04AC13 für die Zeit 01.07.2024 - 30.06.2026

Expected Outcome: the proposals under this call are expected to address one or more of the following subjects : • Enhanced personalized monitoring, care and treatments, focusing on the development of highly customized healthcare solutions, including the required research and diagnostic tools, tailored to individual needs, covering various scenarios such as chronic disease management, physiotherapy, precision diagnosis, personalized medicine/treatment, pre- and postoperative care, and daily assistance in homes and common spaces. It also targets effective management of chronic diseases and elderly care through personalized monitoring and interventions facilitated by advanced sensor technologies and edge-to-cloud solutions. This includes the development and integration of solutions for Hospitalization at Home, enabling patients to receive complex, remotely supervised care using intelligent medical devices capable of sensing, analysing, and transmitting real-time data. This requires a continuum, from in-hospital diagnostics to robust, long-term patient support at home via AI-driven care pathways and hospitalization at home. • Prevention and treatment of diseases, allowing the improved…

Expected Outcome: Proposals submitted to this call are expected to address several of the following elements: • Scaling of wafer-level photonic processes for key materials (e.g. SiN, InP, GaAs),including process integration, yield optimisation, and manufacturability at highvolumes. • Development of packaging and test solutions that are scalable, automated, andcompatible with co-packaged optics and advanced photonic-electronic integration. • Integration of heterogeneous materials and components, such as on-chip lasers,modulators, and detectors, using advanced packaging and assembly approaches. • Design-process-equipment co-optimisation, enabling repeatable, cost-effectiveproduction of complex photonic circuits and systems, including use of PDKs andvalidated building blocks. • Demonstration of system-level functionality through application-relevant use casesin strategic sectors (e.g. AI, sensing, telecommunication, mobility, health, defence),with quantified performance metrics and clear market relevance.

Sweden – Personal care products – Extern Remiss Hygien och städmaterial 2025

Poland – Pharmaceutical products – Dostawa produktów leczniczych wykorzystywanych przez oddziały szpitala, leki stosowane w ramach programów lekowych oraz chemioterapii (część 1)

Spain – Welfare services for children and young people – CONTRATACIÓN DE 74 PLAZAS DE ACOGIMIENTO RESIDENCIAL MENORES. MODALIDAD: VARIAS